• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rapid blood pressure control with minoxidil: acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone system.

作者信息

Grim C E, Luft F C, Grim C M, Klotman P E, Van Huysse J W, Weinberger M H

出版信息

Arch Intern Med. 1979 May;139(5):529-33. doi: 10.1001/archinte.139.5.529.

DOI:10.1001/archinte.139.5.529
PMID:443947
Abstract

Changes in blood pressure, heart rate, electrolyte excretion, and the renin-angiotensin-aldosterone system were monitored before and after minoxidil was added to a regimen of a diuretic and propranolol hydrochloride in 12 severely hypertensive patients. None required more than 40 mg of minoxidil daily for control. On a constant intake, urinary sodium excretion decreased, while urinary potassium excretion remained stable. Heart rate, body weight, and plasma volume increased, while creatinine clearance did not change. Although plasma renin activity increased fourfold, the plasma aldosterone concentration did not increase. Six subjects were restudied after two months of minoxidil treatment. Although blood pressure control continued to be excellent in these subjects, plasma renin values and plasma volume had returned to pretreatment levels. These studies suggest that minoxidil rapidly and effectively lowers blood pressure. Although sodium retention accompanies minoxidil administration acutely, the effect is independent of aldosterone and may be transient.

摘要

相似文献

1
Rapid blood pressure control with minoxidil: acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone system.
Arch Intern Med. 1979 May;139(5):529-33. doi: 10.1001/archinte.139.5.529.
2
Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.用米诺地尔或血管紧张素转换酶抑制剂治疗耐药性高血压:血压、肾素、醛固酮及电解质反应
J Cardiovasc Pharmacol. 1980;2 Suppl 2:S206-16. doi: 10.1097/00005344-198000022-00015.
3
Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.作为米诺地尔诱导血浆肾素活性增加的决定因素,控制血浆肾素活性和交感神经张力的变化。
J Clin Invest. 1975 Feb;55(2):230-5. doi: 10.1172/JCI107926.
4
Increased aldosterone metabolic clearance in hypertensive patients treated with minoxidil: an effect of greater hepatic perfusion.用米诺地尔治疗的高血压患者醛固酮代谢清除率增加:肝脏灌注增加的作用。
J Cardiovasc Pharmacol. 1980;2 Suppl 2:S236-41. doi: 10.1097/00005344-198000022-00018.
5
Effect of minoxidil on blood pressure and hemodynamics in severe hypertension.米诺地尔对重度高血压患者血压及血流动力学的影响。
Am J Cardiol. 1977 May 26;39(6):796-801. doi: 10.1016/s0002-9149(77)80029-5.
6
Catecholamines, renin, aldosterone, and blood volume during chronic minoxidil therapy.慢性米诺地尔治疗期间的儿茶酚胺、肾素、醛固酮和血容量
Klin Wochenschr. 1981 Nov 16;59(22):1231-6. doi: 10.1007/BF01747754.
7
[Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].[长期米诺地尔治疗:肾素、醛固酮、去甲肾上腺素与β受体阻滞剂的必要性]
Schweiz Med Wochenschr. 1978 Nov 4;108(44):1707-9.
8
Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.卡托普利治疗临床高血压。肾素 - 血管紧张素系统各组分及身体成分的变化与血压下降的关系,并附关于转换酶抑制期间血管紧张素II测量的说明
Br Heart J. 1980 Sep;44(3):290-6. doi: 10.1136/hrt.44.3.290.
9
Effect of indapamide on the renin-aldosterone system, and urinary excretion of potassium and calcium in essential hypertension.吲达帕胺对原发性高血压患者肾素 - 醛固酮系统及钾、钙尿排泄的影响。
Br J Clin Pharmacol. 1984 Aug;18(2):229-31. doi: 10.1111/j.1365-2125.1984.tb02458.x.
10
Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.西氯他宁对肾素-血管紧张素-醛固酮系统作用的研究。
Drugs Exp Clin Res. 1988;14(2-3):215-20.

引用本文的文献

1
Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial.血管舒张素对射血分数保留的心力衰竭恶化的影响:一项2期随机试验。
Nat Med. 2025 Aug 31. doi: 10.1038/s41591-025-03939-6.
2
Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories.不同实验室大鼠心脏毒性生物标志物的评估
Toxicol Pathol. 2016 Dec;44(8):1072-1083. doi: 10.1177/0192623316668276. Epub 2016 Sep 28.
3
Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice.
抑制前列腺素转运体PGT可降低高血压大鼠和小鼠的血压。
PLoS One. 2015 Jun 29;10(6):e0131735. doi: 10.1371/journal.pone.0131735. eCollection 2015.
4
Minoxidil: an underused vasodilator for resistant or severe hypertension.米诺地尔:一种未得到充分利用的用于治疗顽固性或重度高血压的血管扩张剂。
J Clin Hypertens (Greenwich). 2004 May;6(5):283-7. doi: 10.1111/j.1524-6175.2004.03585.x.
5
Direct vasodilators and their role in hypertension management: minoxidil.直接血管扩张剂及其在高血压管理中的作用:米诺地尔。
J Clin Hypertens (Greenwich). 2001 Mar-Apr;3(2):110-4. doi: 10.1111/j.1524-6175.2001.00455.x.
6
Drug therapy of renovascular hypertension.肾血管性高血压的药物治疗
Drugs. 1993 Jun;45(6):895-909. doi: 10.2165/00003495-199345060-00003.
7
Chronic treatment with the new potent vasodilator Ro 12-4713 in moderate to severe hypertension: effects on blood pressure, endocrine function, sodium and plasma volume.新型强效血管扩张剂Ro 12 - 4713对中度至重度高血压的长期治疗:对血压、内分泌功能、钠及血浆容量的影响
Eur J Clin Pharmacol. 1981;20(2):79-84. doi: 10.1007/BF00607141.
8
Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.新型血管扩张剂卡普地尔与米诺地尔治疗中重度高血压的对比评估
Eur J Clin Pharmacol. 1982;23(6):483-9. doi: 10.1007/BF00637493.
9
Minoxidil: a review of its pharmacological properties and therapeutic use.米诺地尔:其药理特性与治疗用途综述
Drugs. 1981 Oct;22(4):257-78. doi: 10.2165/00003495-198122040-00001.
10
Acute effects of a new vasodilator, Ro 12-4713, on blood pressure, plasma Renin activity, Aldosterone and Catecholamine levels, and renal function in hypertensive and normal subjects.新型血管扩张剂Ro 12 - 4713对高血压患者和正常受试者血压、血浆肾素活性、醛固酮及儿茶酚胺水平以及肾功能的急性影响。
Eur J Clin Pharmacol. 1981;20(3):169-77. doi: 10.1007/BF00544594.